| 查看: 3085 | 回复: 30 | ||
| 【奖励】 本帖被评价15次，作者whl0903增加金币 8.75 个 | ||
| 当前主题已经存档。 | ||
[资源]
绿宝书的电子版
|
||
|
电子版用起来特别方便！ [ Last edited by whl0903 on 2008-9-2 at 05:06 ] |
回复此楼» 猜你喜欢
308求调剂
已经有4人回复
-
NSFC申报书里申请人简历中代表性论著还需要在申报书最后的附件里面再上传一遍吗
已经有14人回复
-
材料与化工一志愿南昌大学327求调剂推荐
已经有6人回复
-
化学调剂0703
已经有7人回复
-
327求调剂
已经有11人回复
-
调剂
已经有8人回复
-
梁成伟老师课题组欢迎你的加入
已经有7人回复
-
伙伴们，祝我生日快乐吧
已经有24人回复
-
中科院材料273求调剂
已经有3人回复
-
材料工程专硕274一志愿211求调剂
已经有5人回复
2楼2008-09-02 07:33:48
5楼2008-09-02 17:34:40
6楼2008-09-03 07:35:42
7楼2008-09-03 11:05:34
8楼2008-09-03 15:30:49
10楼2008-09-03 19:41:26
11楼2008-09-03 21:08:58
13楼2008-11-02 21:03:08
14楼2008-11-04 09:49:18
15楼2008-11-08 15:52:33
16楼2008-11-08 19:32:39
|
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). A total of 48,440 Enterobacteriaceae isolates collected consecutively from patients hospitalized in participant SENTRY Antimicrobial Surveillance Program sites in four international regions (Asia-Pacific, Europe, Latin America, and North America) were tested by reference broth microdilution method against the most commonly used antimicrobial agents. The most active compounds could be divided in 3 groups based on their spectrum of activity. The first group included meropenem and imipenem, with 99.9% susceptibilty (S) rates for the Enterobacteriaceae. The second group includes amikacin (97.3% S) and cefepime (97.2% S); and a third active group had a rank order of susceptibility of: gatifloxacin = levofloxacin (91.7% S) > ceftazidime (91.4% S) > ceftriaxone (91.2% S) > aztreonam (91.1% S) > gentamicin (90.6% S) > piperacillin/tazobactam = ciprofloxacin (90.5% susceptibility). These latter antimicrobial agents presented susceptibility rates of approximately 90% (89.8%-91.7%). Continued resistance surveillance by various programs remain necessary to monitor the in vitro effectiveness of antimicrobial agents currently used in clinical practice.（9） |
17楼2008-11-09 20:47:39
|
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). A total of 48,440 Enterobacteriaceae isolates collected consecutively from patients hospitalized in participant SENTRY Antimicrobial Surveillance Program sites in four international regions (Asia-Pacific, Europe, Latin America, and North America) were tested by reference broth microdilution method against the most commonly used antimicrobial agents. The most active compounds could be divided in 3 groups based on their spectrum of activity. The first group included meropenem and imipenem, with 99.9% susceptibilty (S) rates for the Enterobacteriaceae. The second group includes amikacin (97.3% S) and cefepime (97.2% S); and a third active group had a rank order of susceptibility of: gatifloxacin = levofloxacin (91.7% S) > ceftazidime (91.4% S) > ceftriaxone (91.2% S) > aztreonam (91.1% S) > gentamicin (90.6% S) > piperacillin/tazobactam = ciprofloxacin (90.5% susceptibility). These latter antimicrobial agents presented susceptibility rates of approximately 90% (89.8%-91.7%). Continued resistance surveillance by various programs remain necessary to monitor the in vitro effectiveness of antimicrobial agents currently used in clinical practice.（9） |
18楼2008-11-09 20:47:54
19楼2008-11-09 22:09:47
21楼2009-03-05 09:52:05
22楼2009-05-24 03:25:27
23楼2009-05-31 01:34:57
24楼2009-07-10 19:22:14
简单回复
wing13443楼
2008-09-02 10:41
回复
谢谢分享！
2008-09-02 12:13
回复
2008-09-03 19:26
回复
glynwell12楼
2008-09-04 01:30
回复
csz0742400320楼
2008-11-10 07:07
回复
谢谢分享！
